FOLLOW US :
  • |
  • |

Equity

Daily Market Tracker
Market Analysis
Other Markets
Corporate Actions
News
Corporate Information

Prev Quarter Comp Home > Equity > Corporate Information > Prev Quarter Comp

Astrazeneca Pharma India LtdIndustry : Pharmaceuticals - Multinational
BSE Code:506820 NSE Symbol: ASTRAZEN P/E (TTM) :129.24
ISIN Demat:INE203A01020 Div & Yield %:0.28 EPS (TTM) :67.05
Book Value (RS) :271.74 Market Cap (Rs Cr.):21663.75 Face Value (RS) :2
    Change Company 
Particulars Quarter Ended
(Dec 2024)		 Quarter Ended
(Dec 2023)		 Quarter Ended
(% Var)
Sales 440.29 305.79 43.98
Other Income 7.98 9.66 -17.39
PBIDT 51.42 24.71 108.09
Interest 0.33 0.61 -45.90
PBDT 51.09 24.10 111.99
Depreciation 9.07 3.70 145.14
PBT 42.02 20.40 105.98
Tax 12.17 4.65 161.72
Deferred Tax -1.00 -0.05 0.00
PAT 30.85 15.80 95.25

IMPORTANT LINKS

QUICK LINKS

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)